- Home
- LVTX vs ICMB Comparison
LVTX vs ICMB Comparison
Compare LVTX & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- ICMB
- Stock Information
- Founded
- LVTX 2016
- ICMB 2012
- Country
- LVTX Netherlands
- ICMB United States
- Employees
- LVTX N/A
- ICMB N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- LVTX Health Care
- ICMB Finance
- Exchange
- LVTX Nasdaq
- ICMB Nasdaq
- Market Cap
- LVTX 40.2M
- ICMB 48.0M
- IPO Year
- LVTX 2021
- ICMB N/A
- Fundamental
- Price
- LVTX $1.48
- ICMB $3.21
- Analyst Decision
- LVTX Strong Buy
- ICMB
- Analyst Count
- LVTX 2
- ICMB 0
- Target Price
- LVTX $6.00
- ICMB N/A
- AVG Volume (30 Days)
- LVTX 56.8K
- ICMB 42.2K
- Earning Date
- LVTX 12-03-2024
- ICMB 11-12-2024
- Dividend Yield
- LVTX N/A
- ICMB 14.95%
- EPS Growth
- LVTX N/A
- ICMB N/A
- EPS
- LVTX N/A
- ICMB 0.29
- Revenue
- LVTX $7,398,000.00
- ICMB $24,827,371.00
- Revenue This Year
- LVTX N/A
- ICMB N/A
- Revenue Next Year
- LVTX N/A
- ICMB N/A
- P/E Ratio
- LVTX N/A
- ICMB $10.99
- Revenue Growth
- LVTX N/A
- ICMB N/A
- 52 Week Low
- LVTX $1.35
- ICMB $2.91
- 52 Week High
- LVTX $6.47
- ICMB $3.96
- Technical
- Relative Strength Index (RSI)
- LVTX 35.08
- ICMB 61.61
- Support Level
- LVTX $1.54
- ICMB $3.03
- Resistance Level
- LVTX $1.65
- ICMB $3.18
- Average True Range (ATR)
- LVTX 0.11
- ICMB 0.09
- MACD
- LVTX -0.04
- ICMB 0.02
- Stochastic Oscillator
- LVTX 3.92
- ICMB 97.69
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.